Group A Streptococcus

Hologic acquires Diagenode for $159 million

Diagenode offers clients more than 30 polymerase chain reaction (PCR) tests, as well as a portfolio of devices, kits, reagents, and antibodies for DNA and RNA analysis.

February 28, 2021

Thermo Fisher completes Mesa Biotech acquisition

Mesa Biotech is known for its Accula system, a point-of-care polymerase chain reaction (PCR)-based testing platform for infectious disease diagnosis. Besides COVID-19, Accula also tests for influenza, respiratory syncytial virus (RSV), and group A Streptococcus.

February 25, 2021

FDA clears Mesa Biotech's point-of-care strep A test

The strep A cassette detects group A Streptococcus bacterial nucleic acid by rapid polymerase chain reaction (PCR). It is approved for use in diagnosing children and adults and provides laboratory quality results within 30 minutes at the point of care.

December 8, 2020

Pathologists advance understanding of deadly female genital tract infections

Group A strep is typically found in the mouth, but it can also infect other mucosal areas of the body, with deadly results. The researchers noted that GAS surface proteins cause an estimated 700 million human infections annually around the world, including 15 million in the U.S. GAS is at the root of puerperal sepsis (also known as childbed fever), which is the leading cause of maternal deaths, and it causes necrotizing myometritis (inflammation of the uterine myometrium) as well as severe infections in newborns.

March 18, 2020

Luminex MRSA test clears FDA

The Aries MRSA assay tests directly for MRSA DNA from nasal swabs in patients at risk for nasal colonization. Clearance was granted on September 25 and announced by the company on October 1.

September 30, 2019

NeuMoDx launches 4 new CE-IVD tests

The assays work with the company's NeuMoDx 96 and NeuMoDx 288 molecular systems.

June 25, 2019